ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ANRO vs CYRX // REVENUE GROWTH (YOY)

Alto Neuroscience Inc. (NYSE) VS. CryoPort Inc. (NASDAQ) • 15-METRIC TALLY: ANRO 0 — CYRX 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANRO VS. CYRX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ANRO CYRX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 47.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -11.50% -23.50 CYRX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.62% -2.70% -2.92 CYRX /fcf-yield <GO>
Operating Margin — -20.90% — TIE /operating-margins <GO>
Net Profit Margin — 44.40% — TIE /net-margins <GO>
Revenue Growth (YoY) ACTIVE — 12.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.33 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 5/9 -2.00 CYRX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.0 56.6 -11.60 CYRX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 9.9x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $921.0M $926.4M -$5.4M CYRX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ANRO REV CYRX REV ANRO GROSS % CYRX GROSS % ANRO FCF CYRX FCF
FY 2025 $0 $176.2M — 47.1% -$51.8M -$25.0M
FY 2024 $0 $156.8M — 44.4% -$49.5M -$33.6M
FY 2023 $0 $168.7M — — -$33.4M -$757.0K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANRO // BETA —
CYRX // BETA —